# TH-CAR-027 for Grade 4 Gliomas

> **NCT07384390** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai Tongji Hospital, Tongji University School of Medicine** · enrollment: 21 (estimated)

## Conditions studied

- R/R Grade 4 Glioma

## Interventions

- **DRUG:** TH-CART-027

## Key facts

- **NCT ID:** NCT07384390
- **Lead sponsor:** Shanghai Tongji Hospital, Tongji University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2028-08-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07384390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07384390, "TH-CAR-027 for Grade 4 Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07384390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*